Skip to content
Intra Mesk Pharma — انترا مسك فارما

Operating Protocol

How Intra Mesk Pharma Works

A transparent view of how we move from market opportunity and product assessment to regulatory coordination, supply, distribution, market activation and ongoing review.

Public Framework

Why we share our operating protocol

Transparency as a Working Principle

Professional relationships are stronger when the way decisions are made is clear. At Intra Mesk Pharma, we believe transparency should extend beyond describing what we do to explaining, at an appropriate public level, how an opportunity moves through our operating model. This is why we share the framework that connects market understanding, product and partner assessment, commercial alignment, regulatory and operational readiness, execution, market monitoring, and review.

The purpose is not to expose confidential business information. It is to give partners, healthcare stakeholders, regulators, professionals, and members of the public a clearer understanding of the logic that connects one stage of our work to the next. A transparent framework helps distinguish the principles that guide our decisions from the confidential details that belong within individual commercial relationships. It also makes clear that progression through the operating cycle depends on the information, readiness, and circumstances relevant to each opportunity.

This protocol is therefore presented as a public operating framework rather than as a universal legal or regulatory procedure. Actual pathways may vary according to product category, regulatory status, partner arrangements, applicable requirements, and the specific circumstances of each engagement.

Clarity Before Commitment

We do not begin with commitment; we begin with understanding. Each opportunity moves through progressive assessment of the market need, product, partner context, commercial alignment, and readiness before the next stage is pursued. Decision points are used to determine whether the available information and conditions justify moving forward, clarifying an issue, holding the opportunity, or returning to an earlier stage.

A Cycle That Learns

Market entry does not mark the end of the operating cycle. Distribution activity, market feedback, quality information, safety signals where applicable, and demand indicators contribute to ongoing review. The resulting information can support continuation, adjustment, further assessment, or a new replenishment cycle. In this way, each operating cycle becomes an input to the next.

The Operating Protocol

The Intra Mesk Operating Protocol

Ten interconnected stages describe the public framework through which we move from market need and opportunity to product assessment, partner engagement, readiness, supply, distribution, market monitoring, and the next operating cycle.

Select a stage to explore its purpose, key actions, expected output, decision gate, and possible next step.

  1. 01

    Market Need & Opportunity

    01 / 10

    Stage Overview

    Every opportunity begins with understanding the need before considering the product. We review relevant market needs and gaps, consider the nature of demand and existing availability, and assess whether there is a credible opportunity that warrants deeper evaluation. The objective is not to react to product availability alone, but to understand whether a meaningful market need exists and whether a potential solution can be approached responsibly and commercially.

    Why This Stage Matters

    A sound operating decision starts with a defined need rather than with the assumption that an available product is automatically a viable opportunity.

    Key Actions

    1. We begin by identifying healthcare or market needs that may justify further consideration of a product or product category. This may involve reviewing gaps in availability, unmet channel requirements, or recurring needs observed through market knowledge and commercial interaction. The purpose is to understand the underlying need rather than simply respond to a product being offered to us. We consider the environment in which a product would operate and the channels through which it may need to reach the market. This initial understanding helps distinguish a meaningful opportunity from a temporary or poorly defined demand signal. It also establishes the context against which later product and partner assessments will be considered. A well-defined need becomes the starting point for a more disciplined evaluation.

    What This Stage Establishes

    A credible opportunity that warrants further assessment, or a clear reason to observe, reconsider, or close the opportunity.

    Decision Gate

    Is there a sufficiently credible opportunity to proceed to product and category assessment?

    • ReassessThe process remains at this stageThe available information is not yet sufficient to justify progression. The opportunity returns to market observation or to the elements requiring further review before a new decision is made.
    ReturnMarket observation / opportunity reassessment

Three Business Lines

One framework, three business lines

The operating framework is shared across our three business lines, while product category, regulatory status, documentation, supply characteristics, handling requirements, and market considerations may differ.

Pharmaceuticals

Selected pharmaceutical categories supported across the full supply pathway.

  • Product & manufacturer assessment
  • Regulatory pathway & import
  • Quality verification
  • Controlled storage & distribution
  • Pharmacovigilance
  • Market monitoring

Medical Supplies

Essential medical supply categories organized for healthcare settings.

  • Category & documentation assessment
  • Regulatory pathway
  • Supply readiness
  • Receiving & verification
  • Storage & distribution
  • Market feedback

Medical Devices

Medical devices supported from import through to installation and training.

  • Category & intended-use assessment
  • Documentation & regulatory pathway
  • Import & receiving
  • Distribution
  • Installation & training where relevant
  • Applicable support considerations

Supporting Capabilities

Capabilities that support the protocol

The protocol does not operate on its own. These enabling functions carry each stage — they support the operating model rather than replace it.

The Relationship Model

Who the operating model connects

The model moves value in both directions — from manufacturers to healthcare channels, and from market feedback back into planning.

  1. Manufacturer / Partner

    Products, documentation and shared market intentions.

  2. Intra Mesk Pharma

    The coordinated operating layer — assessment, agreements, import, supply and market activity.

  3. Regulatory · Quality · Supply

    The control framework every product moves within.

  4. Healthcare Channels

    Pharmacies, hospitals, clinics and programs where products meet care.

    Private PharmaciesHospitalsClinicsGovernment TendersHumanitarian / NGOs
  5. Market Feedback

    Signals that inform review, adjustment and the next cycle.

The Bigger Picture

Why this matters beyond the supply chain

Healthcare supply is not only about moving products. A structured operating model is what makes availability dependable, handling responsible and concerns audible.

Availability

Healthcare products need an organized route from supply source to appropriate channels. Availability depends on more than having products in inventory; it depends on a coordinated operating pathway.

Safety

Product integrity and product safety depend on appropriate handling, communication, monitoring, and reporting throughout the product journey.

Voice

Healthcare professionals and the public need clear channels through which relevant quality or safety concerns can be communicated to the appropriate function.

For Every Audience

Why this model matters to different audiences

The protocol is written for more than commercial counterparties. It gives each audience a clearer view of the part of the operating model that concerns them.

For Manufacturers & Partners

A clearer view of how opportunities are assessed, structured, and moved toward implementation.

For Healthcare Professionals

A better understanding of how product supply, quality, and reporting channels fit into the broader operating model.

For Healthcare Organizations

Greater visibility into how sourcing, storage, distribution, and market coordination connect.

For Patients & Public

Clearer access to information and appropriate channels for product quality and safety concerns.

Explore the Business Lines

Move from the operating protocol to the detail — explore each business line's dedicated page.